Ileal Interposition and Viability of Pancreatic Islets Transplanted into Intramuscular Site of Diabetic Rats

REFERENCES

• Shapiro AM, Lakey JR, Ryan EA, Islet transplantation in seven patients with type I diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–238.
   PubMed Web of Science ®Google Scholar
• Luna A, Julián JF, Alba A, Syngeneic islet transplantation into seminal vesicles of diabetic rats. J Invest Surg. 2005;18:13–18.
   PubMed Web of Science ®Google Scholar
• Narang AS, Mahato RI. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev. 2006;58:194–243.
   PubMed Web of Science ®Google Scholar
• Robertson RP. Islet transplantation as a treatment for diabetes—a work in progress. N Engl J Med. 2004;350:694–705.
   PubMed Web of Science ®Google Scholar
• Bucher P, Mathe Z, Bosco D, Morbidity associated with intraportal islet transplantation. Transplant Proc. 2004;36:1119–1120.
   PubMedGoogle Scholar
• Shapiro AM, Hao EG, Lakey JR, Novel approaches toward early diagnosis of islet allograft rejection. Transplantation 2001;71:1709–1718.
   Google Scholar
• Rajab A. Islet transplantation: alternative sites. Curr Diab Rep. 2010;10:332–337.
   PubMed Web of Science ®Google Scholar
• Goland R, Freeby M, Parsey R, 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med. 2009;50:382–389.
   Google Scholar
• Patriti A, Facchiano E, Annetti C, Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15:1258–1264.
   PubMed Web of Science ®Google Scholar
• Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9: 223–228.
   PubMedGoogle Scholar
• DePaula AL, Macedo AL, Rassi N, Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc. 2008;22:706–716.
   PubMedGoogle Scholar
• Strader AD, Vahl TP, Jandacek RJ, Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 2005;288:447–453.
   PubMed Web of Science ®Google Scholar
• Perfetti R, Zhou J, Doyle ME, Glucagon-like peptide-1induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 2000;141:4600–4605.
   PubMed Web of Science ®Google Scholar
• Li Y, Hansotia T, Yusta B, Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem. 2003;278:471–478.
   PubMed Web of Science ®Google Scholar
• Faradji RN, Monroy K, Messinger S, Simple measures to monitor b-cell mass and assess islet graft dysfunction. Am J Transpl. 2007;7:303–308.
   PubMed Web of Science ®Google Scholar
• Papas KK, Colton CK, Qipo A, Prediction of marginal mass required for successful islet transplantation. J Invest Surg. 2010;23:28–34.
   PubMed Web of Science ®Google Scholar
• Svensson J, Lau J, Sandberg M, High vascular density and oxygenation of pancreatic islets transplanted in clusters into striated muscle. Cell Transplant. 2011;20:783–788.
   PubMed Web of Science ®Google Scholar
• Adams GA, Wang X, Lee LK, Insulin-like growth factor-I promotes successful fetal pancreas transplantation in the intramuscular site. Surgery 1994;116:751–755.
   PubMedGoogle Scholar
• Balamurugan AN, Gu Y, Tabata Y, Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival. Pancreas 2003;26:279–285.
   PubMed Web of Science ®Google Scholar
• Barnett BP, Arepally A, Karmarkar PV, Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med. 2007;13:986–991
   PubMed Web of Science ®Google Scholar
• Barnett BP, Kraitchman DL, Lauzon C, Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol Pharm. 2006;3:531–538.
   PubMedGoogle Scholar
• Barnett BP, Ruiz-Cabello J, Hota P, Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology 2011;258:182–191.
   PubMed Web of Science ®Google Scholar
• van Schilfgaarde R, de Vos P. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med. 1999;77:199–205.
   PubMed Web of Science ®Google Scholar
• Han J, Burgess K. Fluorescent indicators for intracellular pH. Chem Rev. 2010;110:2709–2728.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Nohara H, Kamehara R, Mechanism of apoptosis induced by a lysosomotropic agent, L-leucyl-Lleucine methyl ester. Apoptosis 1999;4:357–362.
   PubMedGoogle Scholar
• Traganos F, Darzynkiewicz Z. Lysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulations. Method Cell Biol. 1994;41:185–194.
   PubMed Web of Science ®Google Scholar
• Leão LRS, Araújo-Filho I, Medeiros AC. Ileal interposition for the treatment of diabetes in rats: repercussion on beta cells mass. J Surg Cl Res. 2011;2:3–14.
   Google Scholar
• Xu G, Stoffers DA, Habener JF, Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999;48:2270–2276.
   PubMed Web of Science ®Google Scholar